Back
Speaker illustration

undefined undefined undefined

Presentations Articles

Early lowering of LDL-C is a more cost-effective strategy than lowering LDL-C later in life: a cost-effectiveness analysis using Mendelian Randomisation

Event: ESC Congress 2023

Topic: Epidemiology

Session: Risk factors and prevention: epidemiology (1)

Access
Like
Thumbnail

Dutch Nationwide Implementation Program for familial hypercholesterolemia case finding in children: a cost-effectiveness and return on investment analysis

Event: ESC Congress 2022

Topic: Health Economics

Session: Costs and cost-effectiveness

Access
Like
Thumbnail

Population genomic screening of all young adults in Australia to detect familial hypercholesterolemia: a cost-effectiveness analysis

Event: ESC Congress 2021 - The Digital Experience

Topic: Cardiovascular Disease in Primary Care

Session: Highlights from the Young in risk factors revisited

Access
Like
Thumbnail

Health economic evaluation of screening and treating children with familial hypercholesterolemia early in life: many happy returns on investment?

Event: ESC Congress 2020

Topic: Health Economics

Session: Global and National Trends in Cardiovascular Disease Mortality, Quality of Care and Economics

Access
Like
Thumbnail

Health economic evaluation of screening and treating children with familial hypercholesterolemia early in life: many happy returns on investment?

Event: ESC Asia with APSC & AFC 2020

Topic: Health Economics

Session: Abstract Programme

Access
Like
Thumbnail

ESC 365 is supported by

novartis Explore sponsored resources